|
26 Companies |
|
24 Products |
|
24 Products |
|
22 Mechanisms of Action |
|
2 Trials |
|
625 News |
|
| «12345678910111213» |
- ||||||| Trial completion: Efficacy and Safety of rhEGF in Diabetic Foot Ulcer Patients With Uncontrolled Diabetic Mellitus (clinicaltrials.gov) - Aug 4, 2014
P3, N=176, Completed, Sponsor: Daewoong Pharmaceutical Co. LTD.
Active, not recruiting --> Completed
- | Enrollment open: A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers (clinicaltrials.gov) - Aug 1, 2014
P2, N=25, Recruiting, Sponsor: Smith & Nephew, Inc.
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Clinical protocol, Trial primary completion date: Topical PluroGel N for the Treatment of Mildly Infected Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 27, 2014
P2, N=50, Recruiting, Sponsor: PluroGen Therapeutics, Inc
Not yet recruiting --> Recruiting Trial primary completion date: Jun 2014 --> Sep 2014
- Clinical protocol, Trial primary completion date: Topical PluroGel PN for the Treatment of Mildly Infected Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 25, 2014
P2, N=25, Recruiting, Sponsor: PluroGen Therapeutics, Inc
Trial primary completion date: Jun 2014 --> Sep 2014 Trial primary completion date: Jun 2014 --> Sep 2014
- Trial primary completion date: Pilot Study on Auricular Vagus Nerve Stimulation Effects in Chronic Diabetic Wounds (clinicaltrials.gov) - Jul 23, 2014
P=N/A, N=20, Recruiting, Sponsor: Medical University of Vienna
Trial primary completion date: Jun 2014 --> Sep 2014 Trial primary completion date: Jun 2014 --> Oct 2014
- Enrollment change: Developing a Home Telehealth Program to Manage Pressure Ulcers in SCI/D (clinicaltrials.gov) - Jul 21, 2014
P=N/A, N=18, Completed, Sponsor: Department of Veterans Affairs
Trial primary completion date: Jun 2014 --> Oct 2014 N=50 --> 18
- Trial primary completion date: PRP-2012: Feasibility and Safety and Evaluation of the Potential Efficacy of Autologous Platelet-rich Plasma in the Treatment of Vascular Venous Ulcers (clinicaltrials.gov) - Jul 18, 2014
P1/2, N=40, Recruiting, Sponsor: Basque Health Service
N=50 --> 18 Trial primary completion date: Dec 2013 --> Dec 2014
- Enrollment change, Trial termination: Effectiveness Study of Santyl Ointment to Treat Pressure Ulcers (clinicaltrials.gov) - Jul 17, 2014
P=N/A, N=2, Terminated, Sponsor: Louisiana State University Health Sciences Center Shreveport
Trial primary completion date: Dec 2013 --> Dec 2014 N=50 --> 2 | Enrolling by invitation --> Terminated; Low enrollment of qualified subjects
- Trial completion, Enrollment change: EPC: Impaired Wound Healing in Diabetic Foot Ulceration (clinicaltrials.gov) - Jul 17, 2014
P=N/A, N=137, Completed, Sponsor: Beth Israel Deaconess Medical Center
N=50 --> 2 | Enrolling by invitation --> Terminated; Low enrollment of qualified subjects Recruiting --> Completed | N=110 --> 137
- gevokizumab (S 78989) / Novartis
Trial primary completion date: Proof of Concept Study of Gevokizumab in the Treatment of Pyoderma Gangrenosum (clinicaltrials.gov) - Jul 14, 2014
P2, N=8, Active, not recruiting, Sponsor: XOMA (US) LLC
Recruiting --> Completed | N=110 --> 137 Trial primary completion date: Jan 2014 --> Oct 2015
- Trial initiation date: ANGIOCATH: To Assess Analgesia Provided by Continuous Sciatic Nerve Block in Patients With Hypertensive Leg Ulcer (clinicaltrials.gov) - Jul 8, 2014
P4, N=30, Recruiting, Sponsor: Nantes University Hospital
Trial primary completion date: Jan 2014 --> Oct 2015 Initiation date: Nov 2013 --> Feb 2014
- Enrollment change: Utilization of Platelet Gel for Treatment of Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 8, 2014
P1/2, N=30, Completed, Sponsor: Royan Institute
Initiation date: Nov 2013 --> Feb 2014 N=244 --> 30
- Enrollment open, Trial initiation date: ANGIOCATH: To Assess Analgesia Provided by Continuous Sciatic Nerve Block in Patients With Hypertensive Leg Ulcer (clinicaltrials.gov) - Jul 8, 2014
P4, N=30, Recruiting, Sponsor: Nantes University Hospital
N=244 --> 30 Not yet recruiting --> Recruiting | Initiation date: Nov 2013 --> Feb 2014
- | New P4 trial: A RCT to Compare the Effects of Two Wound Products on Biofilm Disruption in DFUs (clinicaltrials.gov) - Jul 8, 2014
P4, N=20, Not yet recruiting, Sponsor: Smith & Nephew Medical Ltd
- ||| Enrollment closed: Study of Oasis Ultra in Diabetic Foot Ulcers (clinicaltrials.gov) - Jul 1, 2014
P4, N=100, Active, not recruiting, Sponsor: Healthpoint
Not yet recruiting --> Recruiting | Initiation date: Nov 2013 --> Feb 2014 Recruiting --> Active, not recruiting
- |||| Enrollment open: Study of Oasis Ultra in Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 27, 2014
P4, N=100, Recruiting, Sponsor: Healthpoint
Recruiting --> Active, not recruiting Active, not recruiting --> Recruiting
- Clinical: Comparison of Resin Salve and Octenidine in Patients With Neuropathic Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 24, 2014
P=N/A, N=40, Recruiting, Sponsor: Janne J. Jokinen
- | New P2 trial: CRO-OSTEO: Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis (clinicaltrials.gov) - Jun 22, 2014
P2, N=228, Recruiting, Sponsor: Loyola University
- | Locilex (pexiganan acetate) / PLx Pharma Inc
Enrollment open, Head-to-Head: OneStep-2: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 22, 2014
P3, N=180, Recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Active, not recruiting --> Recruiting Not yet recruiting --> Recruiting
- | Locilex (pexiganan acetate) / PLx Pharma Inc
Enrollment open, Head-to-Head: OneStep-1: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 22, 2014
P3, N=180, Recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- Clinical: CONDUCT I: NEOX® CORD 1K vs Standard of Care in Non-healing Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=30, Recruiting, Sponsor: Amniox Medical, Inc.
- Clinical: A Multicenter, Post Marketing Clinical Follow up (PMCF) Investigation to Evaluate the Performance and Safety of a Soft Silicone Foam Dressing and to Evaluate the Performance of Standard Care in Exuding Venous Leg Ulcers (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=30, Recruiting, Sponsor: Molnlycke Health Care AB
- Trial completion: A Retrospective Study to Assess the Outcome After Surgical Reconstruction of the Midfoot With the Midfoot Fusion Bolt in Patients With Neuroarthropathy (clinicaltrials.gov) - Jun 19, 2014
P=N/A, N=47, Completed, Sponsor: AO Clinical Investigation and Documentation
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- ||| Trial completion: Human Amniotic Membrane Grafting and Standard of Care Versus Standard of Care Alone in the Treatment of Venous Leg Ulcers (clinicaltrials.gov) - Jun 13, 2014
P=N/A, N=98, Completed, Sponsor: MiMedx Group, Inc.
Active, not recruiting --> Completed Recruiting --> Completed
- || Enrollment change: Trial of Dehydrated Human Amnion/Chorion Membrane (dHACM) In the Management of Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 13, 2014
P=N/A, N=84, Recruiting, Sponsor: MiMedx Group, Inc.
Recruiting --> Completed N=120 --> 84
- Locilex (pexiganan acetate) / PLx Pharma Inc
Trial primary completion date, Head-to-Head: OneStep-2: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 12, 2014
P3, N=180, Not yet recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
N=120 --> 84 Trial primary completion date: Feb 2013 --> Oct 2014
- Locilex (pexiganan acetate) / PLx Pharma Inc
Trial primary completion date, Head-to-Head: OneStep-1: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 12, 2014
P3, N=180, Not yet recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Trial primary completion date: Feb 2013 --> Oct 2014 Trial primary completion date: Jul 2013 --> Oct 2014
- | Locilex (pexiganan acetate) / PLx Pharma Inc
Trial initiation date, Head-to-Head: OneStep-2: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 12, 2014
P3, N=180, Not yet recruiting, Sponsor: Dipexium Pharmaceuticals, Inc.
Trial primary completion date: Jul 2013 --> Oct 2014 Initiation date: Oct 2012 --> Jun 2014
- ||||| Locilex (pexiganan acetate) / PLx Pharma Inc
Trial initiation date, Head-to-Head: OneStep-1: Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers (clinicaltrials.gov) - Jun 8, 2014
P3, N=180, Not yet recruiting, Sponsor: Dipexium Pharmaceuticals, LLC
Initiation date: Oct 2012 --> Jun 2014 Initiation date: Oct 2012 --> Mar 2013
- || aspirin / Generic mfg.
New P3 trial: Low Dose Aspirin for Venous Leg Ulcers (clinicaltrials.gov) - Jun 4, 2014
P3, N=354, Not yet recruiting, Sponsor: University of Auckland, New Zealand
- | New P2 trial: A Phase 2 Exploratory Pharmacodynamic Study of HP802-247 in Venous Leg Ulcers (clinicaltrials.gov) - Jun 1, 2014
P2, N=25, Not yet recruiting, Sponsor: Smith & Nephew, Inc.
- || Trial primary completion date: Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds (clinicaltrials.gov) - May 31, 2014
P2, N=72, Recruiting, Sponsor: MediWound Ltd
Initiation date: Oct 2012 --> Mar 2013 Trial primary completion date: Mar 2014 --> May 2015
- |||| Enrollment open: Efficacy and Safety Study of EscharEx to Treat (Debride) Hard to Heal Wounds (clinicaltrials.gov) - May 31, 2014
P2, N=72, Recruiting, Sponsor: MediWound Ltd
Trial primary completion date: Mar 2014 --> May 2015 Not yet recruiting --> Recruiting
- || Trial primary completion date, HEOR: Health Economic Assessment of Lower Extremity Diabetic (HEALED) Ulcers With PriMatrix (clinicaltrials.gov) - May 21, 2014
P=N/A, N=224, Recruiting, Sponsor: TEI Biosciences Inc.
Not yet recruiting --> Recruiting Trial primary completion date: Sep 2014 --> Dec 2014
- Clinical: Open Multi-center Safety & Efficacy Study of Low Frequency Magnetic Fields to Treat Unresponsive Diabetic Foot Ulcers. (clinicaltrials.gov) - May 21, 2014
P=N/A, N=27, Completed, Sponsor: Autonomous University of Morelos
- |||| Clinical data, Enrollment open: Santyl Applications to Diabetic Foot Ulcers (clinicaltrials.gov) - May 19, 2014
P4, N=200, Recruiting, Sponsor: Smith & Nephew, Inc.
Trial primary completion date: Sep 2014 --> Dec 2014 Not yet recruiting --> Recruiting
- Trial primary completion date: Multi-layer Insoles for a Patient-specific Approach to Shear and Pressure Reduction in Diabetes-related Foot Ulcer (clinicaltrials.gov) - May 19, 2014
P=N/A, N=27, Completed, Sponsor: University of Michigan
Not yet recruiting --> Recruiting Trial primary completion date: Apr 2013 --> Jan 2014
- Trial completion date: Multi-layer Insoles for a Patient-specific Approach to Shear and Pressure Reduction in Diabetes-related Foot Ulcer (clinicaltrials.gov) - May 19, 2014
P=N/A, N=27, Completed, Sponsor: University of Michigan
Trial primary completion date: Apr 2013 --> Jan 2014 Trial completion date: May 2013 --> Jan 2014
- Trial completion: Multi-layer Insoles for a Patient-specific Approach to Shear and Pressure Reduction in Diabetes-related Foot Ulcer (clinicaltrials.gov) - May 19, 2014
P=N/A, N=27, Completed, Sponsor: University of Michigan
Trial completion date: May 2013 --> Jan 2014 Active, not recruiting --> Completed
- Trial primary completion date: Wound Fluid Protease Levels During Use of Novel Wound Dressing (clinicaltrials.gov) - May 7, 2014
P4, N=35, Completed, Sponsor: Hollister Incorporated
Active, not recruiting --> Completed Trial primary completion date: Dec 2013 --> Jan 2014
- Trial completion date: Wound Fluid Protease Levels During Use of Novel Wound Dressing (clinicaltrials.gov) - May 7, 2014
P4, N=35, Completed, Sponsor: Hollister Incorporated
Trial primary completion date: Dec 2013 --> Jan 2014 Trial completion date: Feb 2014 --> Jan 2014
- | Trial completion: Wound Fluid Protease Levels During Use of Novel Wound Dressing (clinicaltrials.gov) - May 7, 2014
P4, N=35, Completed, Sponsor: Hollister Incorporated
Trial completion date: Feb 2014 --> Jan 2014 Recruiting --> Completed
- | New P1/2 trial: Utilization of Platelet Gel for Treatment of Diabetic Foot Ulcers (clinicaltrials.gov) - May 7, 2014
P1/2, N=244, Completed, Sponsor: Royan Institute
- ||| Enrollment open: CMS: Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds (clinicaltrials.gov) - May 6, 2014
P=N/A, N=1500, Recruiting, Sponsor: Arteriocyte, Inc.
Recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| Trial initiation date: Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247 (clinicaltrials.gov) - May 4, 2014
P3, N=440, Enrolling by invitation, Sponsor: Smith & Nephew, Inc.
Not yet recruiting --> Recruiting Initiation date: Jan 2014 --> May 2014
- |||||| Enrollment open: Observational Study Providing 12 Months of Safety Follow-Up From First Exposure to HP802-247 (clinicaltrials.gov) - May 4, 2014
P3, N=440, Enrolling by invitation, Sponsor: Smith & Nephew, Inc.
Initiation date: Jan 2014 --> May 2014 Not yet recruiting --> Enrolling by invitation
- Trial suspension: The Use of Bioscaffolds in Conjunction With Negative Pressure Therapy: A Prospective Randomized Double-Blinded Trial (clinicaltrials.gov) - May 4, 2014
P=N/A, N=10, Suspended, Sponsor: TEI Biosciences Inc.
Not yet recruiting --> Enrolling by invitation Recruiting --> Suspended
- New P4 trial: EZCast-DFU Study With Portal for Application of Topical Medications (clinicaltrials.gov) - May 4, 2014
P4, N=3, Not yet recruiting, Sponsor: University of Miami
- Trial primary completion date: Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders (clinicaltrials.gov) - May 2, 2014
P1, N=44, Recruiting, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Recruiting --> Suspended Trial primary completion date: Jun 2013 --> Apr 2015
- Trial completion date: Topical Sodium Nitrite for Chronic Leg Ulcers in Adult Patients With Blood Disorders (clinicaltrials.gov) - May 2, 2014
P1, N=44, Recruiting, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Trial primary completion date: Jun 2013 --> Apr 2015 Trial completion date: Jun 2014 --> Apr 2015